Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.

Paez-Vega A, Cantisan S, Vaquero JM, Vidal E, Luque-Pineda A, Lobo-Acosta MÁ, Pérez AB, Alonso-Moralejo R, Iturbe D, Monforte V, Otero-Gonzalez I, Pastor A, Ussetti P, Torre-Cisneros J.

BMJ Open. 2019 Aug 15;9(8):e030648. doi: 10.1136/bmjopen-2019-030648.

2.

Excellent long-term outcome with lungs obtained from uncontrolled donation after circulatory death.

Suberviola B, Mons R, Ballesteros MA, Mora V, Delgado M, Naranjo S, Iturbe D, Miñambres E.

Am J Transplant. 2019 Apr;19(4):1195-1201. doi: 10.1111/ajt.15237. Epub 2019 Jan 22.

PMID:
30582287
3.

Diagnosis of Idiopathic Pulmonary Fibrosis: Differential Diagnosis.

Aburto M, Herráez I, Iturbe D, Jiménez-Romero A.

Med Sci (Basel). 2018 Sep 4;6(3). pii: E73. doi: 10.3390/medsci6030073. Review.

4.

Screening for Latent Tuberculosis Infection in Patients who are Candidate for Biological Therapies in Spain? A Multidisciplinary Survey.

Quirós S, de la Rosa D, Uranga A, Madero R, Amaro R, Bruguera N, García JA, Gómez C, Iturbe D, Lera R, Luque L, Martínez AJ, Mínguez P, Navarro A, Sánchez G, Suárez-Cuartín G.

Arch Bronconeumol. 2018 Oct;54(10):510-517. doi: 10.1016/j.arbres.2018.04.004. Epub 2018 Jun 23. English, Spanish.

5.

Outcomes in systemic sclerosis-related lung disease after lung transplantation.

Sottile PD, Iturbe D, Katsumoto TR, Connolly MK, Collard HR, Leard LA, Hays S, Golden JA, Hoopes C, Kukreja J, Singer JP.

Transplantation. 2013 Apr 15;95(7):975-80. doi: 10.1097/TP.0b013e3182845f23.

Supplemental Content

Loading ...
Support Center